These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 9285314)
1. Pharmacokinetics of recombinant human erythropoietin in children with chronic renal failure. Cakar N; Ekim M; Tümer N; Yalçinkaya F; Akar N; Onaran HO Int Urol Nephrol; 1997; 29(3):377-83. PubMed ID: 9285314 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Macdougall IC; Roberts DE; Neubert P; Dharmasena AD; Coles GA; Williams JD Lancet; 1989 Feb; 1(8635):425-7. PubMed ID: 2563798 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of subcutaneous and intraperitoneal administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Lui SF; Chung WW; Leung CB; Chan K; Lai KN Clin Nephrol; 1990 Jan; 33(1):47-51. PubMed ID: 2302870 [TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal recombinant human erythropoietin therapy: influence of the duration of continuous ambulatory peritoneal dialysis treatment and peritonitis. Huang TP; Lin CY Am J Nephrol; 1995; 15(4):312-7. PubMed ID: 7573189 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of recombinant human erythropoietin in children treated with continuous ambulatory peritoneal dialysis. Reddingius RE; Schröder CH; Koster AM; Monnens LA Eur J Pediatr; 1994 Nov; 153(11):850-4. PubMed ID: 7843202 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and hematologic response to subcutaneous administration of recombinant human erythropoietin in children undergoing long-term peritoneal dialysis: a multicenter study. Montini G; Zacchello G; Perfumo F; Edefonti A; Bassi S; Cantaluppi A; Sarchi C; Cazzin M; Ferrari V; Boccazzi A J Pediatr; 1993 Feb; 122(2):297-302. PubMed ID: 8429450 [TBL] [Abstract][Full Text] [Related]
7. Subcutaneous erythropoietin administration in predialysis patients: a single centre prospective study. Branger B; Vécina F; Zabadani B; Balducchi JP; Fourcade J Nephrol Dial Transplant; 1995; 10 Suppl 6():36-9. PubMed ID: 8524492 [TBL] [Abstract][Full Text] [Related]
8. Better response to s.c. erythropoietin in CAPD than HD patients. Stegmayr BG Scand J Urol Nephrol; 1997 Apr; 31(2):183-7. PubMed ID: 9165584 [TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal production of erythropoietin with continuous ambulatory peritoneal dialysis. Chandra M; Clemons G; Sahdev I; McVicar M; Bluestone P Pediatr Nephrol; 1993 Jun; 7(3):281-3. PubMed ID: 8518099 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intraperitoneal, intravenous, and subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis. Ateshkadi A; Johnson CA; Oxton LL; Hammond TG; Bohenek WS; Zimmerman SW Am J Kidney Dis; 1993 Jun; 21(6):635-42. PubMed ID: 8503418 [TBL] [Abstract][Full Text] [Related]
11. Leptin and serum erythropoietin in hemodialyzed and peritoneally dialyzed uremic patients during rHuEPO therapy. Małyszko J; Zbroch E; Wołczyński S; Małyszko JS; Hryszko T; Myśliwiec M Am J Nephrol; 2000; 20(3):180-6. PubMed ID: 10878398 [TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacokinetics of recombinant erythropoietin administered by the intravenous, subcutaneous, and intraperitoneal routes in continuous ambulatory peritoneal dialysis (CAPD) patients. Boelaert JR; Schurgers ML; Matthys EG; Belpaire FM; Daneels RF; De Cre MJ; Bogaert MG Perit Dial Int; 1989; 9(2):95-8. PubMed ID: 2488207 [TBL] [Abstract][Full Text] [Related]
14. Erythropoietin in children with chronic renal failure on dialytic and non-dialytic therapy. Aikhionbare HA; Winterborn MW; Gyde OH Int J Pediatr Nephrol; 1987; 8(1):9-14. PubMed ID: 3583560 [TBL] [Abstract][Full Text] [Related]
15. Response of continuous peritoneal dialysis patients to subcutaneous recombinant human erythropoietin differs from that of hemodialysis patients. Besarab A; Golper TA ASAIO Trans; 1991; 37(3):M395-6. PubMed ID: 1751205 [TBL] [Abstract][Full Text] [Related]
16. Role of erythropoietin in the reversal of anemia of renal failure with continuous ambulatory peritoneal dialysis. Chandra M; McVicar M; Clemons G; Mossey RT; Wilkes BM Nephron; 1987; 46(3):312-5. PubMed ID: 3627325 [TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of intraperitoneal erythropoietin administered undiluted or diluted in dialysate. Bargman JM; Jones JE; Petro JM Perit Dial Int; 1992; 12(4):369-72. PubMed ID: 1420495 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of recombinant human erythropoietin applied subcutaneously to children with chronic renal failure. Braun A; Ding R; Seidel C; Fies T; Kurtz A; Schärer K Pediatr Nephrol; 1993 Feb; 7(1):61-4. PubMed ID: 8439481 [TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal erythropoietin in children on peritoneal dialysis: A study of pharmacokinetics and efficacy. Kausz AT; Watkins SL; Hansen C; Godwin DA; Palmer RB; Brandt JR Am J Kidney Dis; 1999 Oct; 34(4):651-6. PubMed ID: 10516345 [TBL] [Abstract][Full Text] [Related]
20. Recombinant human erythropoietin dosage in children undergoing hemodialysis and continuous ambulatory peritoneal dialysis. Sieniawska M; Roszkowska-Blaim M Pediatr Nephrol; 1997 Oct; 11(5):628-30. PubMed ID: 9323294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]